患有野生型TP53但缺陷TP53-介导的尾症的AML患者的生存率很低
Josephine Dubois1, Anthony Palmer2, Darren King1
1Division of Hematology and Oncology, University of Michigan, Ann Arbor, United States of America.
JCI insight
|January 27, 2026
概括
患有急性髓性白血病 (AML) 和TP53突变的患者的生存率很差. 用MDM2抑制剂治疗揭示了TP53-介导的亡的多原因缺陷,导致AML患者的结果极其差.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 患有TP53突变的急性髓性白血病 (AML) 患者表现出令人丧的生存率.
- 像MI219这样的MDM2抑制剂稳定了p53蛋白,但它们在AML中的有效性,特别是在TP53野生型病例中,需要详细的描述.
研究的目的:
- 调查AML爆发对MDM2抑制剂MI219的ex vivo反应,重点关注TP53野生型 (WT) 患者.
- 确定 AML 中对 MDM2 抑制剂诱导的亡产生抗性的分子机制.
- 为了将治疗反应与患者生存结果相关联.
主要方法:
- 用MDM2抑制剂MI219对165名AML患者样本进行了ex vivo治疗.
- 在基线和治疗后对抗性和敏感的TP53 WT AML病例的基于阵列的表达概况.
- 分析TP53突变状态和共同突变 (例如,NPM1) 与治疗反应和生存相关的情况.
主要成果:
- 33%的AML病例耐受MDM2抑制剂诱导的亡,其中45%携带TP53突变,55%是TP53WT.
- 敏感的TP53WT病例显示TP53响应基因的诱导,而耐药病例显示诱导减弱或不存在.
- 耐药和敏感的TP53 WT AML样本在与炎症相关的基因和线粒体基因的基线表达上有显著差异.
- 没有TP53突变AML患者存活; TP53 WT AML与缺陷亡的4年存活率非常差 (19%与NPM1共变,6%与WT NPM1).
结论:
- 在AML中存在TP53-介导的亡中普遍存在的多因性缺陷,导致患者的生存率极低.
- 在TP53 WT AML中对MDM2抑制剂的耐药性与受损的p53通路激活和明显的基线基因表达特征有关.
- 这些发现突显了AML治疗耐药性的复杂性,并强调了对新型治疗策略的需求.
相关概念视频
Apoptosis
14.4K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
14.4K
Survival Curves
698
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
698
Survival Tree
418
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
418
Lumber Defects
509
Lumber defects, which can affect both the appearance and structural integrity of wood, include a variety of growth and manufacturing flaws. Growth defects such as knots and knotholes occur where branches were once attached to the tree trunk, with knotholes forming when these knots fall out. Other natural defects include decay and insect damage, which compromise the wood's strength and durability.
Shakes are minor fractures that run along or across the wood's annual rings, while wane is...
Shakes are minor fractures that run along or across the wood's annual rings, while wane is...
509
Introduction To Survival Analysis
771
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
771
Comparing the Survival Analysis of Two or More Groups
583
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
583


